Clinical Trial Update: A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for radiopharmaceuticals 99mTc-MIP-1404 and 99mTc-MIP-1405 in metastatic prostate cancer and healthy volunteers; study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 99mTc-MIP-1404 (Technetium-99m MIP-1404)
• 99mTc-MIP-1405

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED